Aliquoting Peptide Solutions: Volumes, Losses, Containers and Procedure

Splitting a reconstituted stock into aliquots answers a single problem — the parent vial gets entered once and never again — exchanging a small, calculable transfer loss for freedom from repeated freeze–thaw damage, accumulating septum punctures and single-point-of-failure risk. The choice is not automatic, though: once volumes fall below about 100 µL, adsorption onto container surfaces costs more peptide than freeze–thaw ever would. Below we cover when splitting a stock makes sense and when it does not, the procedure itself, the arithmetic behind transfer losses, and the container decisions that matter most. This concerns handling of laboratory reference solutions.

Four arguments for splitting a stock

1. Damage from freeze–thaw. Every freezing cycle concentrates solutes at the advancing ice front and generates a large ice–water interface, and both promote aggregation — plus disulfide scrambling in peptides that carry one. Published stability studies on peptide and protein solutions frequently report measurable loss after three to five cycles, the precise figure depending strongly on sequence and buffer. An aliquot thaws exactly once.
2. Integrity of the septum. Rubber stoppers withstand only so many punctures before coring debris and leak paths develop. Draw from a stock twenty times and it has been punctured twenty times; split it once and it has been punctured once.
3. Limiting contamination. Compromise one aliquot and you lose that aliquot. Compromise the parent vial on the fifteenth entry and everything goes, with no way of knowing which earlier experiments were affected.
4. Traceability. Individual aliquots can be dated and labelled, so a result points to a specific container rather than to "the vial, some time in March".

When splitting is the wrong call

• Tiny volumes. Because peptides adsorb onto glass and plastic, loss tracks the surface-area-to-volume ratio, which climbs steeply as volume shrinks. A dilute peptide in a 50 µL aliquot can lose a sizeable percentage to the walls of a standard vial, while the same solution held in bulk loses next to nothing.
• Dilute solutions with no carrier. Under roughly 10 µg/mL, adsorption dominates losses whatever the volume. Low-bind containers or a carrier protein such as 0.1% BSA help — but BSA interferes with protein assays and certain immunoassays, making it a design decision rather than a default.
• Brief working lifetimes. A solution destined to be used up within a week in the fridge gains nothing from being divided into freezer aliquots.
• Where the transfer itself carries the risk. Each transfer is a chance to introduce contamination or a pipetting mistake, so if a stock will only be entered two or three times, the parent vial is the safer home.

Worked example: dividing a 10 mg vial

1. Reconstitute. Adding 4 mL of bacteriostatic water to 10 mg gives 10 ÷ 4 = 2.5 mg/mL.
2. Decide the split. Take eight aliquots of 0.5 mL, each containing 0.5 × 2.5 = 1.25 mg of peptide, or 1,250 mcg.
3. Tally the transfer loss. With a fixed-needle insulin syringe holding about 3 µL of dead space, eight transfers strand 8 × 3 = 24 µL. Out of 4,000 µL that is 0.6%, roughly 60 mcg across the vial.
4. Compare with a detachable-needle syringe. At 80 µL of dead space per transfer, those same eight aliquots lose 640 µL — 16%, or 1.6 mg from a 10 mg vial. Choosing the syringe matters more than the decision to aliquot at all.
5. Fill level per container. Half a millilitre in a 3 mL vial fills roughly one sixth of it, leaving plenty of headspace for the roughly 9% expansion aqueous solution undergoes on freezing. Never fill a container destined for the freezer beyond about two thirds.
6. Check the arithmetic. 8 × 1.25 mg = 10 mg, minus 0.6% transfer loss, leaves about 9.94 mg accounted for.

Settling on an aliquot volume

A workable rule: choose the volume that covers a single working session, then confirm it is not under 100 µL. Splitting more finely than your actual usage pattern simply adds transfers and surfaces while achieving nothing.

Step-by-step procedure

1. Reconstitute the parent vial gently: diluent down the wall, swirl instead of shaking, and never vortex. The complete method is in the reconstitution guide.
2. Wait until the cake has dissolved entirely before transferring anything. Splitting a partly dissolved solution spreads concentration unevenly between containers, and that error cannot be detected afterwards.
3. Label the receiving containers before filling them: peptide name, concentration in mg/mL, volume, date and lot number. Vial labels and log sheets exist for this purpose, and labelling afterwards is how aliquots end up anonymous.
4. Wipe each septum with an alcohol prep pad and allow it to dry.
5. Transfer using a fixed-needle syringe such as a 31G insulin syringe into pre-sterilised empty vials, changing the needle if it contacts anything besides the two septa.
6. Keep the volume constant. Draw to the same mark every time rather than dividing whatever remains, or the final aliquot absorbs all the accumulated error.
7. Freeze upright and without delay, since faster freezing produces smaller ice crystals and less interfacial area.
8. Document the split: parent lot, concentration, number and volume of aliquots, date and storage location.

Sterility while splitting

Neither reconstitution nor aliquoting is a sterile procedure outside a laminar-flow cabinet. The 0.9% benzyl alcohol in bacteriostatic water holds microbial growth in check but does not sterilise, and it does nothing about particulates. When a downstream application demands sterility, the usual route is filtering through a 0.22 µm syringe filter into pre-sterilised vials, since heat sterilisation destroys peptides. Expect a small adsorptive loss on the membrane, and pre-rinse the filter with diluent when concentrations are low.

Frequent mistakes

• Splitting before the cake has fully dissolved, leaving containers at genuinely different concentrations.
• Overfilling containers headed for the freezer — aqueous solution expands about 9% and will dislodge a stopper or crack glass.
• Reaching for a detachable-needle syringe and quietly surrendering 15% of the vial to hub dead space.
• Choosing volumes smaller than a working session, so aliquots are refrozen anyway and the entire advantage evaporates.
• Writing only the peptide name on the label. Lacking concentration, date and lot, an aliquot cannot underpin a result.
• Pooling leftovers from several thawed aliquots into one container, which saddles it with the combined freeze–thaw history of all of them.

Storage temperatures and realistic working lifetimes for the resulting aliquots appear in how to store peptides, while the errors this procedure aims to prevent are catalogued in common reconstitution and storage mistakes. Containers and consumables are listed under reconstitution supplies.